Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Dapsone
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Recipient : Cosette Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Cosette Pharmaceuticals Launches Dapsone 5% Gel, AB-Rated to Aczone 5%
Details : Aczone contains dapsone, a sulfone, in an aqueous gel base indicated for the topical treatment of acne vulgaris. It works by killing or preventing the growth of bacteria on the skin.
Product Name : Aczone-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 13, 2023
Lead Product(s) : Dapsone
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Recipient : Cosette Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
